The role of sequential chemoradiation for local advanced oropharyngeal carcinoma
- Liam MastersonAffiliated withDepartment of ENT, Cambridge University Hospitals Trust Email author
- , Faiz TanweerAffiliated withQueens Medical Centre
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
This study aims to assess survival, prognostic indicators, and pattern of failure for advanced oropharyngeal cancer treated by induction chemotherapy followed by concomitant chemoradiation (sequential CRT).
A retrospective review of 80 consecutive patients who underwent chemoradiation [doublet cisplatin and 5-fluorouracil (PF)] for local advanced oropharyngeal carcinoma at a tertiary center from March 2003 to July 2008 is reported. Seven studies utilizing a similar protocol were reviewed, and all outcomes are collated.
At a median follow-up of 32 months, the 3-year overall survival was 75 %. Tumor size (p < 0.001), age at presentation (p < 0.002), and failure to complete the full course of induction chemotherapy (p < 0.01) were all found to be significant factors affecting survival.
Induction chemotherapy followed by concomitant chemoradiation utilizing doublet PF is an effective treatment for local advanced oropharyngeal carcinoma. At present, the addition of a taxane to the PF regimen cannot be assumed to provide benefit until further evidence emerges from a representative controlled trial.
KeywordsOropharyngeal Squamous cell carcinoma Sequential chemoradiation
- The role of sequential chemoradiation for local advanced oropharyngeal carcinoma
International Journal of Clinical Oncology
Volume 18, Issue 5 , pp 808-816
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Squamous cell carcinoma
- Sequential chemoradiation
- Industry Sectors